National Academies Press: OpenBook
« Previous: 5. Barriers to Medical Innovation
Suggested Citation:"Appendix A: Conference Agenda." Institute of Medicine and National Research Council. 2002. Medical Innovation in the Changing Healthcare Marketplace: Conference Summary. Washington, DC: The National Academies Press. doi: 10.17226/10358.
×

Appendixes

Suggested Citation:"Appendix A: Conference Agenda." Institute of Medicine and National Research Council. 2002. Medical Innovation in the Changing Healthcare Marketplace: Conference Summary. Washington, DC: The National Academies Press. doi: 10.17226/10358.
×
This page in the original is blank.
Suggested Citation:"Appendix A: Conference Agenda." Institute of Medicine and National Research Council. 2002. Medical Innovation in the Changing Healthcare Marketplace: Conference Summary. Washington, DC: The National Academies Press. doi: 10.17226/10358.
×

A
Conference Agenda

The National Academies

Board on Science, Technology, and Economic Policy

Board on Health Care Services, Institute of Medicine

Agenda

Conference on Medical Innovation in the Changing Healthcare Marketplace

June 14-15, 2001

National Academies Main Building

2100 C Street, NW, Washington, DC

June 14

8:00 AM

Continental Breakfast

8:30 AM

Welcome and Introduction of Keynote Speaker

Cochair: Ed Penhoet, UC Berkeley

8:35 AM

Keynote AddressEncouraging High-Value Innovation: Medicare and Other Federal Policies

Speaker:

Mark McClellan, Council of Economic Advisers

9:15 AM

Objectives for the Conference

Cochairs: Ed Penhoet, UC Berkeley, and Kathy Behrens, RS Investments

The cochairs will outline the background to and their goals for the conference.

Suggested Citation:"Appendix A: Conference Agenda." Institute of Medicine and National Research Council. 2002. Medical Innovation in the Changing Healthcare Marketplace: Conference Summary. Washington, DC: The National Academies Press. doi: 10.17226/10358.
×

9:45 AM

Report from an NAE Workshop on Engineering and Health Care Delivery Systems

Speaker:

Jerry Grossman, Kennedy School of Government, Harvard University

10:00 AM

Panel I: The Macro Picture—Trends in Health Care Costs and Benefits

This session will examine at the macro level the extent to which new medical technology is driving up health care costs and, the equally important issue of whether new medical technology is bringing more benefits.

Moderator:

Philip Aspden, NRC

Panelists:

 

Sheila Smith, CMS, formerly HCFA

Alison Keith, Pfizer, Inc. (ret.)

Kevin Murphy, University of Chicago

11:15 AM

Break.

11:30 AM

Panel IIA: Cardiovascular Disease—Trends in Health Care Costs and Benefits

In this session the panelists will examine in more detail trends in the costs and benefits of new medical technology by considering cardiovascular disease. The long-term health care cost implications of successful treatment of cardiovascular disease will be considered.

Moderator:

David Gollaher, California Healthcare Institute

Panelists:

 

Elizabeth Nabel, NHLBI

Dan Mark, Duke University

Paul Citron, Medtronic

David Cutler, Harvard University

1:00 PM

Lunch

Suggested Citation:"Appendix A: Conference Agenda." Institute of Medicine and National Research Council. 2002. Medical Innovation in the Changing Healthcare Marketplace: Conference Summary. Washington, DC: The National Academies Press. doi: 10.17226/10358.
×

2:00 PM

Panel IIB: Cardiovascular Disease—Fostering High-Value Medical Innovation

Panelists will examine the barriers to innovation in the development, adoption, and diffusion of new treatments of cardiovascular disease. Ways to overcome identified barriers will also be considered.

Moderator:

Kathy Behrens, RS Investments

Panelists:

 

Tom Fogarty, Stanford University

Mark Hlatky, Stanford University

Laurel Sweeney, Philips Medical Systems

3:30 PM

Break.

3:45 PM

Panel IIIA: Metastatic Melanoma—Trends in Health Care Costs and Benefits

In this session the panelists will examine in more detail trends in the costs and benefits of new medical technology by considering metastatic melanoma. The long-term health care cost implications of successful treatment of metastatic melanoma will be considered.

Moderator:

Gil Omenn, University of Michigan

Panelists:

 

Steven Rosenberg, National Cancer Institute

Mike Atkins, Beth Israel Deaconess Medical Center, Harvard Medical School

Margaret Tucker, National Cancer Institute

Bruce Hillner, Medical College of Virginia

5:30 PM

Close

6:00 PM

Reception

* * * *

Suggested Citation:"Appendix A: Conference Agenda." Institute of Medicine and National Research Council. 2002. Medical Innovation in the Changing Healthcare Marketplace: Conference Summary. Washington, DC: The National Academies Press. doi: 10.17226/10358.
×

June 15

8:00 AM

Continental Breakfast.

8:30 AM

Welcome and Recap

Cochairs: Ed Penhoet, UC Berkeley, and Kathy Behrens, RS Investments

8:45 AM

Key Note Speaker

Speaker:

David Lawrence, Kaiser Permanente

Dr. Lawrence will speak about the recent IOM report, Crossing the Quality Chasm, medical care in the 21st century, the drivers of innovation, and possible public policy levers to foster high-value medical innovation.

9:45 AM

Panel IIIB: Metastatic Melanoma—Fostering High-Value Medical Innovation

Panelists will examine the barriers to innovation in the development, adoption, and diffusion of new treatments of metastatic melanoma. Ways to overcome identified barriers will also be considered.

Moderator:

Ed Penhoet, UC Berkeley

Panelists:

 

Bruce Scharschmidt, Chiron

Richard Pazdur, FDA

Robert Young, Fox Chase Cancer Center

Jonathan Lewis, Antigenics

11:00 AM

Break.

11:15 AM

Panel IV: The Macro Picture—Fostering High-Value Medical Innovation

In this session panelists will examine public policy initiatives at the macro level that will foster the development, adoption, and diffusion of high-value medical innovation.

Suggested Citation:"Appendix A: Conference Agenda." Institute of Medicine and National Research Council. 2002. Medical Innovation in the Changing Healthcare Marketplace: Conference Summary. Washington, DC: The National Academies Press. doi: 10.17226/10358.
×

Moderator:

Alan Garber, Stanford University

Panelists:

 

Susan Bartlett Foote, University of Minnesota

Sean Tunis, CMS, formerly HCFA

Jamie Robinson, UC Berkeley

1:00 PM

Lunch

1:30 PM

Panel IV (cont.): The Macro Picture—Fostering High-Value Medical Innovation

Panelists:

 

Brandon Hull, Cardinal Partners

Fran Visco, National Breast Cancer Coalition

John Ford, House Committee on Energy and Commerce/ Democratic Staff

2:45 PM

Session VI: Wrap-up Discussion

The final session will allow participants to discuss the key issues arising from the conference.

Moderators:

Cochairs: Ed Penhoet, UC Berkeley, Kathy Behrens, RS Investments.

Suggested Citation:"Appendix A: Conference Agenda." Institute of Medicine and National Research Council. 2002. Medical Innovation in the Changing Healthcare Marketplace: Conference Summary. Washington, DC: The National Academies Press. doi: 10.17226/10358.
×
Page 43
Suggested Citation:"Appendix A: Conference Agenda." Institute of Medicine and National Research Council. 2002. Medical Innovation in the Changing Healthcare Marketplace: Conference Summary. Washington, DC: The National Academies Press. doi: 10.17226/10358.
×
Page 44
Suggested Citation:"Appendix A: Conference Agenda." Institute of Medicine and National Research Council. 2002. Medical Innovation in the Changing Healthcare Marketplace: Conference Summary. Washington, DC: The National Academies Press. doi: 10.17226/10358.
×
Page 45
Suggested Citation:"Appendix A: Conference Agenda." Institute of Medicine and National Research Council. 2002. Medical Innovation in the Changing Healthcare Marketplace: Conference Summary. Washington, DC: The National Academies Press. doi: 10.17226/10358.
×
Page 46
Suggested Citation:"Appendix A: Conference Agenda." Institute of Medicine and National Research Council. 2002. Medical Innovation in the Changing Healthcare Marketplace: Conference Summary. Washington, DC: The National Academies Press. doi: 10.17226/10358.
×
Page 47
Suggested Citation:"Appendix A: Conference Agenda." Institute of Medicine and National Research Council. 2002. Medical Innovation in the Changing Healthcare Marketplace: Conference Summary. Washington, DC: The National Academies Press. doi: 10.17226/10358.
×
Page 48
Suggested Citation:"Appendix A: Conference Agenda." Institute of Medicine and National Research Council. 2002. Medical Innovation in the Changing Healthcare Marketplace: Conference Summary. Washington, DC: The National Academies Press. doi: 10.17226/10358.
×
Page 49
Next: Appendix B: Conference Participant List »
Medical Innovation in the Changing Healthcare Marketplace: Conference Summary Get This Book
×
Buy Paperback | $29.00 Buy Ebook | $23.99
MyNAP members save 10% online.
Login or Register to save!

A wave of new health care innovation and growing demand for health care, coupled with uncertain productivity improvements, could severely challenge efforts to control future health care costs. A committee of the National Research Council and the Institute of Medicine organized a conference to examine key health care trends and their impact on medical innovation. The conference addressed the following question: In an environment of renewed concern about rising health care costs, where can public policy stimulate or remove disincentives to the development, adoption and diffusion of high-value innovation in diagnostics, therapeutics, and devices?

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!